Search Results - Michael Borte
- Showing 1 - 20 results of 35
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Interleukin-21 restores immunoglobulin production ex vivo in patients with common variable immunodeficiency and selective IgA deficiency by Stephan Borte, Qiang Pan‐Hammarström, Chonghai Liu, Ulrich Sack, Michael Borte, Ulf Wagner, Dagmar Graf, Lennart Hammarström
Published 2009Artigo -
9
Safety and Efficacy of Privigen®, a Novel 10% Liquid Immunoglobulin Preparation for Intravenous Use, in Patients with Primary Immunodeficiencies by Mark R. Stein, Robert P. Nelson, Joseph A. Church, Richard L. Wasserman, Michael Borte, Christiane Vermylen, Johann Bichler
Published 2008Artigo -
10
Reduced IFN‐γ‐ and enhanced IL‐4‐producing CD4<sup>+</sup> cord blood T cells are associated with a higher risk for atopic dermatitis during the first 2 yr of life by Gunda Herberth, Joachim Heinrich, Stefan Röder, Adina Figl, Michael Weiß, Ulrike Diez, Michael Borte, Olf Herbarth, Irina Lehmann
Published 2009Artigo -
11
Maternal diet during pregnancy in relation to eczema and allergic sensitization in the offspring at 2 y of age by Stefanie Sausenthaler, Sibylle Koletzko, Beate Schaaf, Irina Lehmann, Michael Borte, Olf Herbarth, Andrea von Berg, H‐Erich Wichmann, Joachim Heinrich
Published 2007Artigo -
12
-
13
-
14
Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR by Stephan Borte, Ulrika von Döbeln, Anders Fasth, Ning Wang, Magdalena Janzi, Jacek Winiarski, Ulrich Sack, Qiang Pan‐Hammarström, Michael Borte, Lennart Hammarström
Published 2011Artigo -
15
Levels of Antibodies Specific to Tetanus Toxoid,<i>Haemophilus influenzae</i>Type b, and Pneumococcal Capsular Polysaccharide in Healthy Children and Adults by U. Schauer, Frank Stemberg, Christian Rieger, Wolfgang Büttner, Michael Borte, Simone Schubert, Helga Möllers, Frank Riedel, Udo Herz, Harald Renz, Wilhelm Herzog
Published 2003Artigo -
16
Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy by Jordan S. Orange, B. H. Belohradsky, Madelyn Berger, Michael Borte, John P. Hagan, Stephen Jolles, Richard L. Wasserman, Jeffrey S. Baggish, Rhodri Saunders, Bodo Grimbacher
Published 2012Revisão -
17
Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement by Gerd Horneff, Sigrid Fitter, Ivan Foeldvari, Kirsten Minden, Jasmin Kuemmerle‐Deschner, Nicolay Tzaribacev, A. Thon, Michael Borte, Gerd Ganser, Rolf Trauzeddel, Hans‐Iko Huppertz
Published 2012Artigo -
18
-
19
Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies by Michael Borte, G. Kriván, Beáta Dérfalvi, László Maródi, Thomas Harrer, Stephen Jolles, Christelle Bourgeois, Werner Engl, Heinz Leibl, Barbara McCoy, David Gelmont, Leman Yel
Published 2016Artigo -
20
Longitudinal study on cat allergen exposure and the development of allergy in young children by Chih‐Mei Chen, Peter Rzehak, Anne Zutavern, B Fahlbusch, W. Bischof, Olf Herbarth, Michael Borte, Irina Lehmann, Heidrun Behrendt, Ursula Krämer, H.‐Erich Wichmann, Joachim Heinrich
Published 2007Artigo
Search Tools:
Related Subjects
Medicine
Immunology
Internal medicine
Biology
Genetics
Pediatrics
Antibody
Disease
Allergy
Primary immunodeficiency
Immune system
Pregnancy
Environmental health
Gene
Intensive care medicine
Adverse effect
Cord blood
Atopy
Endocrinology
Immunodeficiency
Immunoglobulin G
Incidence (geometry)
Odds ratio
Offspring
Optics
Pathology
Physics
Rheumatoid arthritis
Rheumatology
Vaccination